Discontinuation Rate of Dual Antiretroviral Therapy With Dolutegravir Plus Lamivudine in People Living With HIV: A Systematic Review. RSD 2022, 11 (12), e430111234758. https://doi.org/10.33448/rsd-v11i12.34758.